87 related articles for article (PubMed ID: 24719956)
1. Clinicopathological characteristics and chronology of p53 expression in the development of gastric cancer.
Karim S; Mirza Z; Naseer MI; Al-Qahtani MH; Ali A
Hepatogastroenterology; 2013; 60(128):2113-8. PubMed ID: 24719956
[TBL] [Abstract][Full Text] [Related]
2. Biological prognostic parameters in gastric carcinomas.
Potecă T; Potecă A; Sajin M; Comănescu M
Chirurgia (Bucur); 2014; 109(3):347-54. PubMed ID: 24956340
[TBL] [Abstract][Full Text] [Related]
3. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
[TBL] [Abstract][Full Text] [Related]
4. The immunohistochemical expression of the p53-protein in gastric carcinomas. Correlation with clinicopathological factors and survival of patients.
Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Raţiu I; Vernic C
Rom J Morphol Embryol; 2010; 51(2):249-57. PubMed ID: 20495739
[TBL] [Abstract][Full Text] [Related]
5. Minute gastric carcinoma of differentiated type with special reference to the significance of intestinal metaplasia, proliferative zone, and p53 protein during tumor development.
Sasaki I; Yao T; Nawata H; Tsuneyoshi M
Cancer; 1999 Apr; 85(8):1719-29. PubMed ID: 10223565
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of p53 is associated with growth pattern and prognosis in advanced gastric cancer.
Ichiyoshi Y; Oiwa H; Tomisaki S; Sakaguchi Y; Ohno S; Maehara Y; Sugimachi K
Hepatogastroenterology; 1997; 44(14):546-53. PubMed ID: 9164535
[TBL] [Abstract][Full Text] [Related]
7. The association between the p53/topoisomerase I and p53/ topoisomerase IIalpha immunophenotypes and the progression of ovarian carcinomas.
Bar JK; Grelewski P; Noga L; Rabczyński J; Gryboś M; Jeleń M
Adv Clin Exp Med; 2012; 21(1):35-42. PubMed ID: 23214297
[TBL] [Abstract][Full Text] [Related]
8. The clinical significance of p53 accumulation in gastric carcinoma.
Starzynska T; Markiewski M; Domagala W; Marlicz K; Mietkiewski J; Roberts SA; Stern PL
Cancer; 1996 May; 77(10):2005-12. PubMed ID: 8640663
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of p53 protein in gallbladder carcinoma in North India.
Misra S; Chaturvedi A; Goel MM; Mehrotra R; Sharma ID; Srivastava AN; Misra NC
Eur J Surg Oncol; 2000 Mar; 26(2):164-7. PubMed ID: 10744937
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical HER2 expression not associated with clinicopathological characteristics of stage I-III gastric cancer patients.
Chen XZ; Zhang WH; Yao WQ; Liu JP; Zhou ZG; Chen ZX; Zhang B; Chen JP; Mo XM; Hu JK
Hepatogastroenterology; 2014 Sep; 61(134):1817-21. PubMed ID: 25436385
[TBL] [Abstract][Full Text] [Related]
11. The prognostic relevance of fascin expression in human gastric carcinoma.
Hashimoto Y; Shimada Y; Kawamura J; Yamasaki S; Imamura M
Oncology; 2004; 67(3-4):262-70. PubMed ID: 15557788
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and p53 gene alteration comparison between young and older patients with gastric cancer.
Karim S
Asian Pac J Cancer Prev; 2014; 15(3):1375-9. PubMed ID: 24606468
[TBL] [Abstract][Full Text] [Related]
13. Expression of polo-like kinase 1 (PLK1) protein predicts the survival of patients with gastric carcinoma.
Kanaji S; Saito H; Tsujitani S; Matsumoto S; Tatebe S; Kondo A; Ozaki M; Ito H; Ikeguchi M
Oncology; 2006; 70(2):126-33. PubMed ID: 16645325
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of the immunohistochemical detection of p53 protein in endoscopic biopsy specimens.
Jiang H; Han P; Jiang Y; Liang X; Hu C; Yang D
Chin Med J (Engl); 1997 Mar; 110(3):202-5. PubMed ID: 9594341
[TBL] [Abstract][Full Text] [Related]
15. High CD40 expression in gastric cancer associated with expanding type histology and liver metastasis.
Lo SS; Wu CW; Chi CW; Li AF; Chen JH; Lui WY
Hepatogastroenterology; 2005; 52(66):1902-4. PubMed ID: 16334803
[TBL] [Abstract][Full Text] [Related]
16. The overexpression of c-met as a prognostic indicator for gastric carcinoma compared to p53 and p21 nuclear accumulation.
Drebber U; Baldus SE; Nolden B; Grass G; Bollschweiler E; Dienes HP; Hölscher AH; Mönig SP
Oncol Rep; 2008 Jun; 19(6):1477-83. PubMed ID: 18497953
[TBL] [Abstract][Full Text] [Related]
17. Differences in clinicopathological findings, cell kinetics and p53 expression between early gastric cancers with and without Helicobacter pylori infection.
Mitsuhashi J; Mitomi H; Tanabe S; Koizumi W; Kikuchi S; Ojima T; Okayasu I; Saigenji K
Hepatogastroenterology; 2004; 51(60):1636-40. PubMed ID: 15532794
[TBL] [Abstract][Full Text] [Related]
18. The predictive effect of cadherin-17 on lymph node micrometastasis in pN0 gastric cancer.
Wang J; Yu JC; Kang WM; Wang WZ; Liu YQ; Gu P
Ann Surg Oncol; 2012 May; 19(5):1529-34. PubMed ID: 22009269
[TBL] [Abstract][Full Text] [Related]
19. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
[TBL] [Abstract][Full Text] [Related]
20. p53 is an indicator of tumor progression in early but not advanced gastric carcinomas.
Ishii HH; Gobe GC; Ebihara Y
Hepatogastroenterology; 2007; 54(79):2159-63. PubMed ID: 18251181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]